Emerging Treatment Options of Pluronic in Designing Colloidal Nano and Microcarriers Carriers for Various Therapies
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Poloxamers, commonly known as Pluronics, are a special family of synthetic tri-block copolymers with a core structure made of hydrophobic poly (propylene oxide) chains sandwiched by two hydrophilic poly (ethylene oxide) chains. It is possible to modify the mechanical, bioactive, and microstructural characteristics of Pluronics to simulate the behavior of different types of tissues. Additionally, they are auspicious drug carriers with the capacity to increase therapeutic agent availability and to design nano-drug formulations for various ailments. The nanoformulation composed of Pluronics is more susceptible to cancer cells due to their amphiphilic nature and feature of selfassembling into micelles. Today's expanding poloxamer research is creating new hopes that increase the possibility of new remedies for a brand-new nanomedicine age treatment. This article provides a concise overview of the classification, grading, and attributes of drug delivery systems (DDSs) as well as the potential for Pluronics to create micro and nanocarriers. We subsequently discuss its utility in drug delivery for cancer, gene therapy, anti-infective therapy, antioxidants, anti-diabetic drugs, anti-HIV, Alzheimer's disease, and antimicrobial drugs. This review also highlighted several patented formulations that contain various grades of Pluronics in one or more different ways. The recent findings in fundamental research in the field properly demonstrate the strong interest in these novel pharmaceutical strategies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Recent patents on nanotechnology - (2023) vom: 07. Nov. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mathur, Pooja [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Advanced nano-drug. |
|---|
| Anmerkungen: |
Date Revised 29.11.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.2174/0118722105255391231018112747 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365093785 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365093785 | ||
| 003 | DE-627 | ||
| 005 | 20231226100936.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/0118722105255391231018112747 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1216.xml |
| 035 | |a (DE-627)NLM365093785 | ||
| 035 | |a (NLM)38018214 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mathur, Pooja |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Emerging Treatment Options of Pluronic in Designing Colloidal Nano and Microcarriers Carriers for Various Therapies |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 29.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a Poloxamers, commonly known as Pluronics, are a special family of synthetic tri-block copolymers with a core structure made of hydrophobic poly (propylene oxide) chains sandwiched by two hydrophilic poly (ethylene oxide) chains. It is possible to modify the mechanical, bioactive, and microstructural characteristics of Pluronics to simulate the behavior of different types of tissues. Additionally, they are auspicious drug carriers with the capacity to increase therapeutic agent availability and to design nano-drug formulations for various ailments. The nanoformulation composed of Pluronics is more susceptible to cancer cells due to their amphiphilic nature and feature of selfassembling into micelles. Today's expanding poloxamer research is creating new hopes that increase the possibility of new remedies for a brand-new nanomedicine age treatment. This article provides a concise overview of the classification, grading, and attributes of drug delivery systems (DDSs) as well as the potential for Pluronics to create micro and nanocarriers. We subsequently discuss its utility in drug delivery for cancer, gene therapy, anti-infective therapy, antioxidants, anti-diabetic drugs, anti-HIV, Alzheimer's disease, and antimicrobial drugs. This review also highlighted several patented formulations that contain various grades of Pluronics in one or more different ways. The recent findings in fundamental research in the field properly demonstrate the strong interest in these novel pharmaceutical strategies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Poloxamer | |
| 650 | 4 | |a advanced nano-drug. | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a gene therapy | |
| 650 | 4 | |a nanomedicine | |
| 650 | 4 | |a patent | |
| 650 | 4 | |a pluronics | |
| 700 | 1 | |a Verma, Ravinder |e verfasserin |4 aut | |
| 700 | 1 | |a Rani, Laxmi |e verfasserin |4 aut | |
| 700 | 1 | |a Kamboj, Sweta |e verfasserin |4 aut | |
| 700 | 1 | |a Kamboj, Rohit |e verfasserin |4 aut | |
| 700 | 1 | |a Kamboj, Tanu |e verfasserin |4 aut | |
| 700 | 1 | |a Bhatt, Shailendra |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Recent patents on nanotechnology |d 2007 |g (2023) vom: 07. Nov. |w (DE-627)NLM185115284 |x 2212-4020 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:07 |g month:11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/0118722105255391231018112747 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 07 |c 11 | ||